<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>Nootropic Watchdog</title>
  <link>https://www.nootropicwatchdog.com/</link>
  <description>Science-Backed Reviews. No Hype. No BS.</description>
  <language>en</language>
  <lastBuildDate>Wed, 02 Sep 2026 04:32:28 GMT</lastBuildDate>
  <atom:link href="https://www.nootropicwatchdog.com/feed.xml" rel="self" type="application/rss+xml"/>
  <item>
    <title>Your DNA and Your Nootropic Stack: What APOE Genetic Testing Can and Cannot Tell You</title>
    <link>https://www.nootropicwatchdog.com/dna-apoe-genetic-testing-nootropic-stack-what-it-can-cannot-tell-you/</link>
    <guid isPermaLink="true">https://www.nootropicwatchdog.com/dna-apoe-genetic-testing-nootropic-stack-what-it-can-cannot-tell-you/</guid>
    <description>Consumer genetic testing has made it possible for anyone to learn their APOE status in days — but does that information meaningfully change how you should approach nootropic supplementation? The science on gene-supplement interactions is more nuanced than the personalized nutrition industry suggests, and some findings carry implications that go well beyond optimizing a stack.</description>
    <author>Nootropic Watchdog</author>
    <category>Safety &amp; Analysis</category>
    <pubDate>Wed, 02 Sep 2026 04:26:20 GMT</pubDate>
  </item>
  <item>
    <title>Recall Pills Under the Microscope: What the Clinical Evidence Actually Says About Memory Supplements</title>
    <link>https://www.nootropicwatchdog.com/recall-pills-under-the-microscope-clinical-evidence-memory-supplements/</link>
    <guid isPermaLink="true">https://www.nootropicwatchdog.com/recall-pills-under-the-microscope-clinical-evidence-memory-supplements/</guid>
    <description>Phosphatidylserine, huperzine A, and vinpocetine dominate the memory supplement market with bold recall claims — but independent research tells a far more complicated story. We examined the clinical literature behind each compound to determine whether the science justifies the marketing, or whether consumers are paying a premium for placebo-adjacent products.</description>
    <author>Nootropic Watchdog</author>
    <category>Investigative Reviews</category>
    <pubDate>Wed, 02 Sep 2026 04:26:20 GMT</pubDate>
  </item>
  <item>
    <title>Belief, Bias, and Brain Supplements: Unpacking the Placebo Problem in Nootropics</title>
    <link>https://www.nootropicwatchdog.com/placebo-effect-nootropics-cognitive-bias-self-assessment/</link>
    <guid isPermaLink="true">https://www.nootropicwatchdog.com/placebo-effect-nootropics-cognitive-bias-self-assessment/</guid>
    <description>Millions of Americans spend billions of dollars annually on nootropic supplements, yet a significant portion of reported cognitive improvements may trace back not to active compounds but to the brain&#039;s own expectation machinery. Understanding the neurological and psychological mechanisms behind placebo-driven enhancement is not merely an academic exercise—it is a prerequisite for honest self-evaluation. This investigation examines the clinical evidence, explores what neuroimaging reveals about b</description>
    <author>Nootropic Watchdog</author>
    <category>Investigative Reviews</category>
    <pubDate>Wed, 02 Sep 2026 00:25:52 GMT</pubDate>
  </item>
  <item>
    <title>Fix Your Sleep Before You Fix Your Stack: The Evidence for Sleep-First Nootropic Strategy</title>
    <link>https://www.nootropicwatchdog.com/sleep-optimization-nootropics-magnesium-theanine-apigenin-cognitive-performance/</link>
    <guid isPermaLink="true">https://www.nootropicwatchdog.com/sleep-optimization-nootropics-magnesium-theanine-apigenin-cognitive-performance/</guid>
    <description>Before investing in expensive cognitive enhancers, there is a foundational variable most nootropic users chronically undervalue: sleep architecture. The scientific literature is unambiguous that even mild, sustained sleep deficiency degrades the very cognitive domains that nootropic stacks claim to enhance—and certain well-studied compounds may offer meaningful support for sleep quality. This analysis evaluates the clinical evidence for sleep-targeted supplements and makes the case that optimizi</description>
    <author>Nootropic Watchdog</author>
    <category>Safety &amp; Analysis</category>
    <pubDate>Wed, 02 Sep 2026 00:25:52 GMT</pubDate>
  </item>
  <item>
    <title>Separating Signal from Noise: A Science-First Look at ADHD Nootropics and the Brands Cashing In</title>
    <link>https://www.nootropicwatchdog.com/adhd-nootropics-evidence-vs-marketing-claims/</link>
    <guid isPermaLink="true">https://www.nootropicwatchdog.com/adhd-nootropics-evidence-vs-marketing-claims/</guid>
    <description>The market for supplements promising to tame ADHD symptoms has exploded into a multi-billion-dollar industry, but how much of the science actually holds up? We reviewed the clinical literature on the most-hyped ingredients — L-theanine, NAC, alpha-GPC, and more — to determine which products earn their shelf space and which are riding a wave of clever marketing. The results are more nuanced, and more sobering, than most brands would like you to know.</description>
    <author>Nootropic Watchdog</author>
    <category>Investigative Reviews</category>
    <pubDate>Tue, 01 Sep 2026 20:25:52 GMT</pubDate>
  </item>
  <item>
    <title>The Stacking Gamble: What Nootropic Brands Won&#039;t Tell You About Combining Brain Supplements</title>
    <link>https://www.nootropicwatchdog.com/nootropic-stacking-safety-risks-evidence-analysis/</link>
    <guid isPermaLink="true">https://www.nootropicwatchdog.com/nootropic-stacking-safety-risks-evidence-analysis/</guid>
    <description>Nootropic stacking — the practice of combining multiple cognitive supplements simultaneously — has become one of the fastest-growing trends in the brain health space. Proponents claim synergistic benefits that exceed what any single ingredient can deliver; critics point to a near-complete absence of long-term safety data on combinations and a troubling number of unacknowledged drug-supplement interactions. This analysis cuts through the optimization rhetoric to ask a question the industry rarely</description>
    <author>Nootropic Watchdog</author>
    <category>Safety &amp; Analysis</category>
    <pubDate>Tue, 01 Sep 2026 20:25:52 GMT</pubDate>
  </item>
</channel>
</rss>